In a 3-year-old girl with a diffuse reticular erythematous rash, prior facial erythema, nasal congestion, and headache, and a sibling with similar self‑limited illness, what is the most likely diagnosis and which bone‑marrow precursor does the causative virus infect?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Diagnosis: Erythema Infectiosum (Fifth Disease) Caused by Parvovirus B19

The correct answer is E (A + C): This is a Parvovirus B19 infection that infects early erythroid precursors in the bone marrow.

Clinical Reasoning

This 3-year-old presents with the classic triad of erythema infectiosum (fifth disease):

  1. "Slapped cheek" appearance (facial erythema 2 days prior)
  2. Reticular (lacy, net-like) rash on trunk and extremities
  3. Prodromal symptoms (nasal congestion, headache) preceding the rash

The sibling with identical self-limited symptoms strongly supports a contagious viral etiology, which is characteristic of Parvovirus B19 transmission through respiratory droplets 1.

Why Parvovirus B19?

The clinical presentation is pathognomonic for erythema infectiosum 2, 3:

  • Stage 1: Facial erythema with "slapped cheek" appearance occurs first
  • Stage 2: Diffuse reticular/lacy erythema spreads to trunk, extremities, and buttocks (typically sparing palms and soles)
  • Stage 3: Evanescence and recrudescence over approximately 3 weeks

The reticular exanthem on the limbs is present in 100% of cases, while cheek exanthema occurs in approximately 90% 4. This lacy pattern helps distinguish erythema infectiosum from other viral exanthems 2.

Bone Marrow Tropism

Parvovirus B19 specifically infects early erythroid precursors in the bone marrow 2. This tropism explains:

  • Why the virus causes transient aplastic crisis in patients with chronic hemolytic anemias
  • The mechanism of hydrops fetalis in pregnant women
  • Why immunocompromised patients can develop persistent anemia

This is NOT a lymphocyte precursor infection (ruling out option B), distinguishing it from viruses like EBV or CMV.

Why Not Coxsackievirus?

While coxsackievirus can cause maculopapular rashes 1, it does not produce:

  • The characteristic "slapped cheek" appearance
  • The distinctive reticular/lacy pattern on extremities
  • The specific two-stage progression (facial → body rash)

Coxsackievirus typically causes hand-foot-mouth disease or nonspecific viral exanthems without this pathognomonic pattern.

Management Approach

Treatment is symptomatic and supportive 2:

  • Reassurance that the condition is self-limited
  • Antihistamines if pruritus present (occurs in ~50% of cases)
  • No isolation needed once rash appears (patient no longer contagious)
  • Monitor for complications in high-risk patients

Critical Caveats

When to worry about Parvovirus B19:

  • Chronic hemolytic anemia (sickle cell, hereditary spherocytosis): Risk of transient aplastic crisis
  • Immunocompromised patients: Risk of persistent infection and chronic anemia
  • Pregnancy exposure: Risk of hydrops fetalis (requires maternal counseling)
  • Arthralgia/arthritis: More common in adults than children

The diagnosis is primarily clinical 2, 3. Serologic testing (IgM/IgG) is reserved for atypical presentations, immunocompromised patients, pregnant exposures, or when complications develop.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.